Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections

SpeeDx

Status: Not yet enrolling

Conditions: Gonorrhea; Diagnosis; Resistance Bacterial

Study type: Observational

Funder types: Other; Industry; Other U.S. Federal agency

Identifiers

NCT06352554

75A50122C00028 (Other Grant/Funding Number)

2023/ETH02474:STING

224842/Z/21/Z (Other Grant/Funding Number)

Details and patient eligibility

About

This study aims to validate a novel antibiotic susceptibility test (InSignia) for gonorrhoea in patient clinical samples.

The hypothesis is that the InSignia test will be able to detect transcriptional responses after incubation in antibiotic for susceptible strains and not resistant strains.

Furthermore, this study will also add to our understanding on the performance of this test in various clinical specimens.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Confirmed/suspected NG infection
• Willingness to give written informed consent as well as to participate in and comply with the study.

Exclusion criteria

• Currently taking or having taken any antibiotics in the preceding 14 days
• English fluency below level required to understand study procedures
• Unwilling or unable to comply with study procedures